Writer Raises $200M Series C at $1.9B Valuation to Fuel Leadership in Agentic Enterprise AI November 12, 2024
Enveda Biosciences Announces $55M in New Funding to Accelerate Platform and Advance Multiple Candidates to Clinical Trials June 16, 2024
Writer Raises $200M Series C at $1.9B Valuation to Fuel Leadership in Agentic Enterprise AI November 12, 2024
Enveda Biosciences Announces $55M in New Funding to Accelerate Platform and Advance Multiple Candidates to Clinical Trials June 16, 2024